Cargando…
Lessons learned from Ebola Vaccine R&D during a public health emergency
In spite of a complete lack of Research and Development (R&D) preparedness, the 2013–2016 West-Africa Ebola experience demonstrated that it is possible to compress R&D timelines to less than a single year, from a more usual decade or longer. This is mostly to be credited to an unprecedented...
Autor principal: | Kieny, Marie-Paule |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183317/ https://www.ncbi.nlm.nih.gov/pubmed/29452047 http://dx.doi.org/10.1080/21645515.2018.1442161 |
Ejemplares similares
-
Seasonal vaccines – Critical path to pandemic influenza response
por: Zhang, Wenqing, et al.
Publicado: (2017) -
The 2014 Ebola outbreak: ethical use of unregistered interventions
por: Krech, Ruediger, et al.
Publicado: (2014) -
Health-system resilience: reflections on the Ebola crisis in western Africa
por: Kieny, Marie-Paule, et al.
Publicado: (2014) -
Informing the establishment of the WHO Global Observatory on Health Research and Development: a call for papers
por: Adam, Taghreed, et al.
Publicado: (2015) -
Data sharing in public health emergencies: a call to researchers
por: Dye, Christopher, et al.
Publicado: (2016)